NCT02422602已完成不适用
Better Adherence With New Oral Anticoagulant in Atrial Fibrillation : Effectiveness of a Personalized Education Program
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 196
- 试验地点
- 1
- 主要终点
- The occurence of serious adverse event
研究概览
简要总结
This study is multicentric, single-blind, and interventional with a randomization into two parallel arm, between a standard of care information and an additional information of the patient, with a 12 month follow up.
The aim of this study is to evaluate the effectiveness of a personalized information program versus information provided from standard of care in patients taking Xarelto for Stroke Prevention in Atrial Fibrillation.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Investigator)
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients treated with rivaroxaban chronically, (atrial fibrillation non-valvular under current AMM) for less than one year whatever anti vitamin K treatment history
- •Affiliate or beneficiary of a social security system.
- •Patient who formulated its "does not oppose" to participate in this research
- •Age higher than or equal to 18 years
排除标准
- •Opposition to participation
- •Patient don't understand french language
- •Patient does not have responsibility for the management of treatment (treatment administered by a nurse at home, or by caregivers)
- •Tutorship or curatoship
- •Law-protected patient
- •Pregnant women or breast-feeding
研究组 & 干预措施
Taking conventional charge
Active Comparator
No further information is given to the patient during the first and only contact with the nurse of the coordinator center. A time will be dedicated by the IDE to answer questions of the patient.
干预措施: Xarelto (Drug)
结局指标
主要结局
The occurence of serious adverse event
时间窗: 12 months
The occurence of serious adverse event
次要结局
- The number ok hospitalization(12 months)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Assessment of Adherence to New Oral anTicoagulants in Atrial Fibrillation patiEnts Within the Outpatient registrYAtrial FibrillationNCT03790917National Research Center for Preventive Medicine201
招募中
不适用
Comparison Between Direct Oral Anticoagulation (DOAC) Interruption and DOAC Continuation in Patients Undergoing Elective Invasive Coronary Angiography or Percutaneous Coronary InterventionAnticoagulantsAtrial FibrillationCoronary Artery DiseaseNCT04977076Zuyderland Medisch Centrum1,270
已完成
3 期
Prolonged Anticoagulation After a First Episod of Idiopathic Proximal Deep Vein Thrombosis (PADIS TVP)Recurrent Venous ThromboembolismIdiopathic Deep Vein ThrombosisNCT00740493University Hospital, Brest104
已完成
不适用
Keep it SIMPLE: Improving Anti-Coagulation Medication AdherenceMedication AdherenceAtrial FibrillationNCT02690649Tammy Toscos160
尚未招募
3 期
DIrect Oral Anticoagulation and Bioprothesis Aortic ValveAortic Valve DiseaseNCT05687448Assistance Publique - Hôpitaux de Paris1,500